EDITORIAL FOCUSProliferating cardiac microtubulesGeorge Cooper IVGeorge Cooper IVPublished Online:01 Aug 2009https://doi.org/10.1152/ajpheart.00517.2009This is the final version - click for previous versionMoreSectionsPDF (40 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInEmailWeChat identifying the mechanisms underlying the transition from adaptive cardiac hypertrophy to maladaptive cardiac failure has long been a central goal of basic and clinical cardiovascular science. Such studies at the level of the cardiocyte have focused largely on the cardiac motor, i.e., the myofilament, as well as the fuel for that motor, i.e., the mitochondrion, and the governor of its activity, i.e., the sarcoplasmic reticulum. Although multiple abnormalities of each of these components have been identified, especially after the transition to heart failure, it has been much less clear that changes in these systems fully account for the earliest, and thus etiologically most important, deterioration of contractile function that prevents the increase in mass of hypertrophied myocardium from compensating indefinitely for increasing loads.Because the myofilaments function not only within a biochemical setting outlined above but also within a physical setting defined by the extramyofilament cytoskeleton, this latter factor began to attract attention in the 1980s (22). Since cardiocyte ultrastructure during physiological hypertrophy differs very little, if at all, from that during pathological hypertrophy prior to the onset of cardiac failure (19) and since the microtubule component of the extramyofilament cytoskeleton closely invests the myofilaments but is very difficult to discern in striated muscle via standard light or electron microscopy, my colleagues and I decided in 1992 to see if there was a previously unrecognized difference in the microtubule network during an equivalent degree and duration of physiological vs. pathological hypertrophy. Such turned out to be the case, in that we found that pathological pressure overloading, but not physiological volume overloading, produced a dense microtubule network that imposed a viscous load on the shortening sarcomere to cause contractile dysfunction that was reversible on microtubule depolymerization (29, 31, 32). In the years since then, as reviewed elsewhere (9), we have extended this observation to both cardiac ventricles in multiple species at the levels of sarcomere, cell, and tissue in vitro and to the intact heart, including that of humans, in vivo. Apart from these studies of cardiocyte and cardiac mechanics, we found that the increase in microtubule network density and stability is associated with upregulation of α- and β-tubulin (21, 28) and MAP4 (23), a fibrous microtubule-associated protein that stabilizes microtubules. Furthermore, transgenic or hypertrophic MAP4 upregulation itself was shown to cause microtubule network densification and associated abnormalities of contractile function and kinesin-based microtubule transport function (6, 9, 25), and microtubule stabilization via expression of a mutant β-tubulin in the hearts of otherwise normal transgenic mice reproduced the cardiac hypertrophic microtubule phenotype (7).It is, however, important to point out that not all investigators who have looked for this cytoskeletal alteration in experimental models of pressure-overload cardiac hypertrophy have replicated these findings (2). Although, as reviewed in detail elsewhere (9), there are many factors that might be responsible for this variation, a mechanism-based explanation may now be available. That is, since microtubule network densification in our hands is neither species nor chamber specific, an underlying and unifying reason for interlaboratory variation may well be that, as we have shown (see Fig. 8 and related discussion in Ref. 25), this cytoskeletal change does not happen with modest pressure-overload hypertrophy but, instead, only happens with very substantial pressure overloading leading to increased wall stress and an approximate doubling of ventricular mass. Nonetheless, despite the variable early results, there are now a number of other investigators who have confirmed the basic finding of increased tubulin and microtubules in animal models of clinical heart disease and in clinical heart disease itself (1, 3–5, 10, 11, 13–18, 26, 28, 30, 33, 34), with an extraordinary increase in microtubule protein seen after chronic severe pressure overloading (18).Our own work has focused tightly on microtubule derangements that selectively affect cardiac growth and function during pathological, high-wall-stress pressure-overload hypertrophy. An especially important example of the broadening, or “proliferation,” of the pathophysiological setting of this cytoskeletal abnormality has been provided by the work from Jutta Schaper's laboratory (14, 24) on advanced clinical cardiac disease. For instance, in the hearts of patients with dilated cardiomyopathy, several cytoskeletal proteins, including tubulin, desmin, and vinculin, are found to be upregulated, whereas the myofilament proteins are found to be downregulated. Indeed, in their hands, such cytoskeletal changes are characteristic of end-stage clinical cardiac disease.In this issue of the American Journal of Physiology: Heart and Circulatory Physiology, Fassett et al. (12) provide at least one new way to begin to understand the selective presence of microtubule network densification in various forms of maladaptive, decompensated cardiac hypertrophy and failure and its absence from physiological, compensated cardiac hypertrophy. Thus they report that adenosine not only prevents the microtubule accumulation that otherwise occurs in isolated cardiocytes in response to specific hypertrophic stimuli, but a lack of extracellular adenosine production induced genetically was found to amplify the degree of microtubule accumulation seen in response to cardiac pressure overloading. These data are especially interesting in the context of the current understanding of myocardial production of the antiadrenergic agent adenosine, where it is increased in compensated cardiac hypertrophy but returns to normal or is decreased in decompensated cardiac hypertrophy (see Fig. 1 in Ref. 20). Thus, Fassett et al. provide important new hints about the upstream signaling events that may be responsible for increased myocardial microtubules and the potential proliferation of this cytoskeletal abnormality into other settings such as those studied by Schaper's group (14, 24), wherein persistent myocardial adrenergic activation is quite commonly present.GRANTSWork from the author's laboratory that is discussed here was supported by a Department of Veterans Affairs Merit Review Grant and by National Heart, Lung, and Blood Institute Program Project Grant HL-48788.REFERENCES1 Aquila-Pastir LA, DiPaola NR, Matteo RG, Smedira NG, McCarthy PM, Moravec CS. Quantitation and distribution of β-tubulin in human cardiac myocytes. J Mol Cell Cardiol 34: 1513–1523, 2002.Crossref | PubMed | ISI | Google Scholar2 Bailey BA, Dipla K, Li S, Houser SR. Cellular basis of contractile derangements of hypertrophied feline ventricular myocytes. J Mol Cell Cardiol 29: 1823–1835, 1997.Crossref | PubMed | ISI | Google Scholar3 Belmadani S, Pous C, Ventura-Clapier R, Fischmeister R, Mery PF. Post-translational modifications of cardiac tubulin during chronic heart failure in the rat. Mol Cell Biochem 237: 39–46, 2002.Crossref | PubMed | ISI | Google Scholar4 Brown JH, Del Re DP, Sussman MA. The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. Circ Res 98: 730–742, 2006.Crossref | PubMed | ISI | Google Scholar5 Buscemi N, Murray C, Doherty-Kirby A, Lajoie G, Sussman MA, Van Eyk JE. Myocardial subproteomic analysis of a constitutively active Rac1-expressing transgenic mouse with lethal myocardial hypertrophy. Am J Physiol Heart Circ Physiol 289: H2325–H2333, 2005.Link | ISI | Google Scholar6 Cheng G, Qiao F, Gallien TN, Kuppuswamy D, Cooper G. Inhibition of β-adrenergic receptor trafficking in adult cardiocytes by MAP4 decoration of microtubules. Am J Physiol Heart Circ Physiol 288: H1193–H1202, 2005.Link | ISI | Google Scholar7 Cheng G, Zile MR, Takahashi M, Baicu CF, Bonnema DD, Cabral F, Menick DR, Cooper G. A direct test of the hypothesis that increased microtubule network density contributes to contractile dysfunction of the hypertrophied heart. Am J Physiol Heart Circ Physiol 294: H2231–H2241, 2008.Link | ISI | Google Scholar8 Cooper G. Cardiocyte cytoskeleton in hypertrophied myocardium. Heart Fail Rev 5: 187–201, 2000.Crossref | PubMed | Google Scholar9 Cooper G. Cytoskeletal networks and the regulation of cardiac contractility: microtubules, hypertrophy, and cardiac dysfunction. Am J Physiol Heart Circ Physiol 291: H1003–H1014, 2006.Link | ISI | Google Scholar10 Davis FJ, Pillai JB, Gupta M, Gupta MP. Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of α-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility. Am J Physiol Heart Circ Physiol 288: H1477–H1490, 2005.Link | ISI | Google Scholar11 Eble DM, Spinale FG. Contractile and cytoskeletal content, structure and mRNA levels with tachycardia-induced cardiomyopathy. Am J Physiol Heart Circ Physiol 268: H2426–H2439, 1995.Link | ISI | Google Scholar12 Fassett J, Xu X, Hu X, Zhu G, French J, Chen Y, Bache RJ. Adenosine regulation of microtubule dynamics in cardiac hypertrophy. Am J Physiol Heart Circ Physiol (June 12, 2009). doi:10.1152/ajpheart.00462.2009.Link | ISI | Google Scholar13 Hein S, Kostin S, Heling A, Maeno Y, Schaper J. The role of the cytoskeleton in heart failure. Cardiovasc Res 45: 273–278, 2000.Crossref | PubMed | ISI | Google Scholar14 Heling A, Zimmermann R, Kostin S, Maeno Y, Hein S, Devaux B, Bauer E, Klovekorn WP, Schlepper M, Schaper W, Schaper J. Increased expression of cytoskeletal, linkage and extracellular proteins in failing human myocardium. Circ Res 86: 846–853, 2000.Crossref | PubMed | ISI | Google Scholar15 Howarth FC, Qureshi MA, White E, Calaghan S. Cardiac microtubules are more resistant to chemical depolymerisation in streptozotocin-induced diabetes in the rat. Pflügers Arch 444: 432–437, 2002.Crossref | PubMed | ISI | Google Scholar16 Ishibashi Y, Tsutsui H, Yamamoto S, Takahashi M, Imanaka-Yoshida K, Yoshida T, Urabe Y, Sugimachi M, Takeshita A. Role of microtubules in myocyte contractile dysfunction during cardiac hypertrophy in the rat. Am J Physiol Heart Circ Physiol 271: H1978–H1987, 1996.Link | ISI | Google Scholar17 Kostin S, Hein S, Arnon E, Scholz D, Schaper J. The cytoskeleton and related proteins in the human failing heart. Heart Fail Rev 5: 271–280, 2000.Crossref | PubMed | Google Scholar18 Lemler MS, Bies RD, Frid MG, Sastravaha A, Zisman LS, Bohlmeyer T, Gerdes AM, Reeves JT, Stenmark KR. Myocyte cytoskeletal disorganization and right heart failure in hypoxia-induced neonatal pulmonary hypertension. Am J Physiol Heart Circ Physiol 279: H1365–H1376, 2000.Link | ISI | Google Scholar19 Marino TA, Kent RL, Uboh CE, Fernandez E, Thompson EW, Cooper G. Structural analysis of cat right ventricular pressure versus volume overload hypertrophy. Am J Physiol Heart Circ Physiol 249: H371–H379, 1985.Link | ISI | Google Scholar20 Meyer TE, Chung ES, Perlini S, Norton GR, Woodiwiss AJ, Lorbar M, Fenton RA, Dobson JG. Antiadrenergic effects of adenosine in pressure overload hypertrophy. Hypertension 37: 862–868, 2001.Crossref | PubMed | ISI | Google Scholar21 Narishige T, Blade KL, Ishibashi Y, Nagai T, Hamawaki M, Menick DR, Kuppuswamy D, Cooper G. Cardiac hypertrophic and developmental regulation of the β-tubulin multigene family. J Biol Chem 274: 9692–9697, 1999.Crossref | PubMed | ISI | Google Scholar22 Samuel JL, Bertier B, Bugaisky L, Marotte F, Swynghedauw B, Schwartz K, Rappaport L. Different distributions of microtubules, desmin filaments and isomyosins during the onset of cardiac hypertrophy in the rat. Eur J Cell Biol 34: 300–306, 1984.PubMed | ISI | Google Scholar23 Sato H, Nagai T, Kuppuswamy D, Narishige T, Koide M, Menick DR, Cooper G. Microtubule stabilization in pressure overload cardiac hypertrophy. J Cell Biol 139: 963–973, 1997.Crossref | PubMed | ISI | Google Scholar24 Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, Friedl A, Bleese N. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 83: 504–514, 1991.Crossref | PubMed | ISI | Google Scholar25 Scholz D, Baicu CF, Tuxworth WJ, Xu L, Kasiganesan H, Menick DR, Cooper G. Microtubule-dependent distribution of mRNA in adult cardiocytes. Am J Physiol Heart Circ Physiol 294: H1135–H1144, 2008.Link | ISI | Google Scholar26 Scopacasa BS, Teixeira VP, Franchini KG. Colchicine attenuates left ventricular hypertrophy but preserves cardiac function of aortic-constricted rats. J Appl Physiol 94: 1627–1633, 2003.Link | ISI | Google Scholar27 Shiels H, O'Connell A, Qureshi MA, Howarth FC, White E, Calaghan S. Stable microtubules contribute to cardiac dysfunction in the streptozotocin-induced model of type 1 diabetes in the rat. Mol Cell Biochem 294: 173–180, 2007.Crossref | PubMed | ISI | Google Scholar28 Tagawa H, Rozich JD, Narishige T, Kuppuswamy D, Tsutsui H, McDermott PJ, Koide M, Cooper G. Basis for increased microtubules in pressure hypertrophied cardiocytes. Circulation 93: 1230–1243, 1996.Crossref | PubMed | ISI | Google Scholar29 Tagawa H, Wang N, Narishige T, Ingber DE, Zile MR, Cooper G. Cytoskeletal mechanics in pressure-overload cardiac hypertrophy. Circ Res 80: 281–289, 1997.Crossref | PubMed | ISI | Google Scholar30 Takahashi M, Tsutsui H, Tagawa H, Igarashi-Saito K, Imanaka-Yoshida K, Takeshita A. Microtubules are involved in early hypertrophic responses of myocardium during pressure overload. Am J Physiol Heart Circ Physiol 275: H341–H348, 1998.Link | ISI | Google Scholar31 Tsutsui H, Ishihara K, Cooper G. Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium. Science 260: 682–687, 1993.Crossref | PubMed | ISI | Google Scholar32 Tsutsui H, Tagawa H, Kent RL, McCollam PL, Ishihara K, Nagatsu M, Cooper G. Role of microtubules in contractile dysfunction of hypertrophied cardiocytes. Circulation 90: 533–555, 1994.Crossref | PubMed | ISI | Google Scholar33 Wang X, Li F, Campbell SE, Gerdes AM. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs. II. Cytoskeletal remodeling. J Mol Cell Cardiol 31: 319–331, 1999.Crossref | PubMed | ISI | Google Scholar34 Watson PA, Hannan R, Carl LL, Giger KE. Contractile activity and passive stretch regulate tubulin mRNA and protein content in cardiac myocytes. Am J Physiol Cell Physiol 271: C684–C689, 1996.Link | ISI | Google ScholarAUTHOR NOTESAddress for reprint requests and other correspondence: G. Cooper IV, Gazes Cardiac Research Institute, PO Box 250773, Medical Univ. of South Carolina, 114 Doughty St., Charleston, SC 29403 (e-mail: [email protected]) Download PDF Previous Back to Top Next FiguresReferencesRelatedInformationCited ByStrain-dependent stress relaxation behavior of healthy right ventricular free wallActa Biomaterialia, Vol. 152Implications of the complex biology and micro-environment of cardiac sarcomeres in the use of high affinity troponin antibodies as serum biomarkers for cardiac disordersJournal of Molecular and Cellular Cardiology, Vol. 143Differential Effects of Colchicine on Cardiac Cell Viability in an in vitro Model Simulating Myocardial Infarction17 February 2016 | Cardiology, Vol. 134, No. 1Dynamic of Ion Channel Expression at the Plasma Membrane of CardiomyocytesElise Balse, David F. Steele, Hugues Abriel, Alain Coulombe, David Fedida, and Stéphane N. Hatem1 July 2012 | Physiological Reviews, Vol. 92, No. 3Cytoskeletal role in protection of the failing heart by β-adrenergic blockadeGuangmao Cheng, Harinath Kasiganesan, Catalin F. Baicu, J. Grace Wallenborn, Dhandapani Kuppuswamy, and George Cooper1 February 2012 | American Journal of Physiology-Heart and Circulatory Physiology, Vol. 302, No. 3 More from this issue > Volume 297Issue 2August 2009Pages H510-H511 Copyright & PermissionsCopyright © 2009 the American Physiological Societyhttps://doi.org/10.1152/ajpheart.00517.2009PubMed19542487History Published online 1 August 2009 Published in print 1 August 2009 Metrics